View Future GrowthNRoboticsLtd 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 NRoboticsLtd 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2020최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 17NRobotics Co.,Ltd., Annual General Meeting, Mar 31, 2026NRobotics Co.,Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 16, mtv 28-ro, gyeonggi-do, siheung South KoreaNew Risk • Mar 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.1b (US$89.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (23% average weekly change). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩130.1b market cap, or US$89.0m).New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 59% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩129.5b market cap, or US$87.9m).New Risk • Jan 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₩74.0b market cap, or US$51.2m).New Risk • Dec 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₩63.2b market cap, or US$42.9m).공시 • Oct 31Hyupjin Co., Ltd. announced that it expects to receive KRW 10 billion in fundingHyupjin Co., Ltd. announced a private placement of Unregistered Interest Private Convertible Bonds to raise up to KRW 10,000,000,000 on October 29, 2025. The bonds are 100% convertible into 11,792,452 equity shares at a conversion value of KRW 848. The conversion billing periods starts from November 28, 2026 through October 28, 2028. The bonds being issued hold a Maturity Interest Rate of 3%. The bonds carry a payment date of November 28, 2025.공시 • Oct 30Hyupjin Co., Ltd. announced that it expects to receive KRW 25.00000016 billion in fundingHyupjin Co., Ltd. announced a private placement to issue 13,513,514 shares at an issue price of KRW 740 per share for gross proceeds of KRW 10,000,000,360 and 20,270,270 shares at an issue price of KRW 740 per share for gross proceeds of 14,999,999,800; aggregate gross proceeds of KRW 25,000,000,160 on October 29, 2025. The transaction will include participation from Irholdings Co., Ltd. 6,756,757 and Plutos New Normal No. 2 New Technology Fund 6,756,757 shares. The transaction has been approved by shareholders, expected to close December 29, 2025. 20,270,270 shares - The transaction has been approved by shareholders, expected to close December 30, 2025.공시 • Oct 14+ 1 more updateHyupjin Co., Ltd. (KOSDAQ:A138360) agreed to acquire an additional 2.66% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) for KRW 4.1 billion.Hyupjin Co., Ltd. (KOSDAQ:A138360) agreed to acquire an additional 2.66% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) for KRW 4.1 billion on October 13, 2025. The transaction is expected to close on November 14, 2025.New Risk • Apr 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩45.5b market cap, or US$32.0m).공시 • Apr 05Hyupjin Co., Ltd. (KOSDAQ:A138360) completed the acquisition of 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. for KRW 5.0 billion.Hyupjin Co., Ltd. (KOSDAQ:A138360) acquired 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. for KRW 5.0 billion on April 3, 2025. A cash consideration of KRW 4 billion will be paid by Hyupjin Co., Ltd. As part of consideration, KRW 4 billion is paid towards common equity of Kwangmu Co.,Ltd. Hyupjin Co., Ltd. (KOSDAQ:A138360) completed the acquisition of 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. on April 3, 2025.공시 • Mar 08Hyupjin Co., Ltd., Annual General Meeting, Mar 31, 2025Hyupjin Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 16, emtibeui 28-ro, gyeonggi-do, siheung South KoreaNew Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 40% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩29.9b market cap, or US$20.5m).New Risk • Jul 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 40% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Shareholders have been diluted in the past year (40% increase in shares outstanding). Market cap is less than US$100m (₩43.1b market cap, or US$31.1m).New Risk • Nov 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩38.7b market cap, or US$30.0m).매출 및 비용 세부 내역NRoboticsLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A138360 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비30 Sep 2010,018-2,6875,021030 Jun 2010,8891204,113031 Mar 2014,283-3693,769031 Dec 1918,776-1084,294030 Sep 1920,462-25,38518,028030 Jun 1919,214-28,32318,593031 Mar 1917,700-34,36718,041031 Dec 1819,298-34,34818,175030 Sep 1819,552-7,2293,46322930 Jun 1821,777-4,9723,17022931 Mar 1823,2721,5362,92622931 Dec 1724,0534,2412,70222930 Sep 1724,1768,657-3108430 Jun 1723,2217,5884918431 Mar 1725,4107,2251,8508431 Dec 1624,2174,3982,3998430 Sep 1623,763-8835,616030 Jun 1623,2094464,481031 Mar 1620,9541,2143,244031 Dec 1520,0041,8372,595030 Sep 1521,1343,2562,701030 Jun 1521,1983,7282,8770양질의 수익: A138360가 고품질 수익을 갖고 있는지 판단하기에는 데이터가 부족합니다.이익 마진 증가: 지난 1년 동안 A138360의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 A138360의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: A138360의 지난해 수익 성장률을 5년 평균과 비교하기에 데이터가 부족합니다.수익 대 산업: A138360의 지난 해 수익 증가율이 Chemicals 업계 평균을 상회했는지 판단하기에 데이터가 부족합니다.자기자본이익률높은 ROE: A138360는 현재 수익성이 없으므로 자본 수익률이 음수(0%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 22:26종가2026/05/22 00:00수익2020/09/30연간 수익2019/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스NRobotics Co.,Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 17NRobotics Co.,Ltd., Annual General Meeting, Mar 31, 2026NRobotics Co.,Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 16, mtv 28-ro, gyeonggi-do, siheung South Korea
New Risk • Mar 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.1b (US$89.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (23% average weekly change). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩130.1b market cap, or US$89.0m).
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 59% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩129.5b market cap, or US$87.9m).
New Risk • Jan 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₩74.0b market cap, or US$51.2m).
New Risk • Dec 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₩63.2b market cap, or US$42.9m).
공시 • Oct 31Hyupjin Co., Ltd. announced that it expects to receive KRW 10 billion in fundingHyupjin Co., Ltd. announced a private placement of Unregistered Interest Private Convertible Bonds to raise up to KRW 10,000,000,000 on October 29, 2025. The bonds are 100% convertible into 11,792,452 equity shares at a conversion value of KRW 848. The conversion billing periods starts from November 28, 2026 through October 28, 2028. The bonds being issued hold a Maturity Interest Rate of 3%. The bonds carry a payment date of November 28, 2025.
공시 • Oct 30Hyupjin Co., Ltd. announced that it expects to receive KRW 25.00000016 billion in fundingHyupjin Co., Ltd. announced a private placement to issue 13,513,514 shares at an issue price of KRW 740 per share for gross proceeds of KRW 10,000,000,360 and 20,270,270 shares at an issue price of KRW 740 per share for gross proceeds of 14,999,999,800; aggregate gross proceeds of KRW 25,000,000,160 on October 29, 2025. The transaction will include participation from Irholdings Co., Ltd. 6,756,757 and Plutos New Normal No. 2 New Technology Fund 6,756,757 shares. The transaction has been approved by shareholders, expected to close December 29, 2025. 20,270,270 shares - The transaction has been approved by shareholders, expected to close December 30, 2025.
공시 • Oct 14+ 1 more updateHyupjin Co., Ltd. (KOSDAQ:A138360) agreed to acquire an additional 2.66% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) for KRW 4.1 billion.Hyupjin Co., Ltd. (KOSDAQ:A138360) agreed to acquire an additional 2.66% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) for KRW 4.1 billion on October 13, 2025. The transaction is expected to close on November 14, 2025.
New Risk • Apr 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩45.5b market cap, or US$32.0m).
공시 • Apr 05Hyupjin Co., Ltd. (KOSDAQ:A138360) completed the acquisition of 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. for KRW 5.0 billion.Hyupjin Co., Ltd. (KOSDAQ:A138360) acquired 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. for KRW 5.0 billion on April 3, 2025. A cash consideration of KRW 4 billion will be paid by Hyupjin Co., Ltd. As part of consideration, KRW 4 billion is paid towards common equity of Kwangmu Co.,Ltd. Hyupjin Co., Ltd. (KOSDAQ:A138360) completed the acquisition of 4.22% stake in Kwangmu Co.,Ltd. (KOSDAQ:A029480) from Atlas8000 Co., Ltd. on April 3, 2025.
공시 • Mar 08Hyupjin Co., Ltd., Annual General Meeting, Mar 31, 2025Hyupjin Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 16, emtibeui 28-ro, gyeonggi-do, siheung South Korea
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 40% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩29.9b market cap, or US$20.5m).
New Risk • Jul 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 40% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Shareholders have been diluted in the past year (40% increase in shares outstanding). Market cap is less than US$100m (₩43.1b market cap, or US$31.1m).
New Risk • Nov 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2020 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩38.7b market cap, or US$30.0m).